Last edition
News about "Invasive Meningococcal Disease (IMD)"
EU Approves Sanofi's MenQuadfi for Invasive Meningococcal Disease
Sanofi's MenQuadfi has received European Union (EU) approval for infants from 6 weeks of age, expanding protection against invasive meningococcal disease.
Invasive Meningococcal Disease (IMD) | 04/08/2026 | By News Bureau
EMA Accepts Bexsero Label Update for Meningitis B Booster
The European Medicines Agency (EMA) has accepted a label update for Bexsero that could enable a single booster dose to protect individuals aged 10 years and older previously vaccinated against Meningitis B.
Invasive Meningococcal Disease (IMD) | 21/07/2026 | By News Bureau | 128
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy